Researchers have discovered that the microbial metabolite TMA acts as a natural IRAK4 inhibitor, blocking inflammation and ...

The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

Researchers revealed that the microbial metabolite TMA can directly block the immune protein IRAK4, reducing inflammation and ...

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

The molecule counteracts damage caused by high-fat diets and even protects mice from sepsis. Since IRAK4 is a known drug target, this pathway could inspire new diabetes therapies. The study highlights ...

An international research team led by Professor Marc-Emmanuel Dumas at Imperial College London & CNRS together with Prof.

Gut-microbe–derived trimethylamine (TMA) blocks a key immune protein, reducing inflammation and improving blood-sugar control.

The coexistence of type 2 diabetes and obesity represents a major global health challenge that significantly increases cardiovascular and metabolic risk.

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research ...